NCT01779271View on ClinicalTrials.gov

Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 31, 2016

Conditions
Acute Upper Respiratory InfectionFever
Interventions
DRUG

Pelubiprofen

DRUG

Loxoprofen

Trial Locations (1)

Unknown

Chung-Ang University Hospital, South Korea, Seoul

Sponsors
All Listed Sponsors
lead

Daewon Pharmaceutical Co., Ltd.

INDUSTRY

NCT01779271 - Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection | Biotech Hunter | Biotech Hunter